"Our Physicians and Physician Assistants treat patients with a variety of general endocrinology needs: Diabetes, Thyroid & Cholesterol Disorders, Hormonal Imbalances and Testosterone Deficiencies."

During the past decade, Endocrinology Services NorthWest conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Endocrinology Services NorthWest" are "Morbid Obesity" (1 trials) and "Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Endocrinology Services NorthWest" in a lesser frequency.

Most popular intervention types in "Endocrinology Services NorthWest" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Exenatide" (1 trials), "Insulin Degludec" (1 trials), "Insulin Glargine" (1 trials), "Insulin Lispro" (1 trials) and "LY900014" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endocrinology Services NorthWest" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Endocrinology Services NorthWest". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Endocrinology Services NorthWest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endocrinology Services NorthWest, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".